Business
Trading update and notice of results
Inspiration Healthcare Group plc reported a strong first-half performance for the six months ended 31 July 2025, exceeding market expectations. Revenue increased by 41% to £24.0 million compared to £17.0 million in the same period last year. This growth was driven by a favourable product mix, including strong sales of capital items, leading to improved gross margins and profitability. A $6 million humanitarian aid contract was fully delivered, with most payments received; the remainder is expected in early H2. Net debt decreased by £1.6 million to £6.7 million, a positive indicator of the company's financial health. The company anticipates continued strong sales momentum into the second half of the year and will announce its interim results on 7 October 2025. Disclaimer*
About this update from Inspiration Healthcare Group Plc
[{"type":"text","content":"\n\nInspiration Healthcare Group plc\n(\"Inspiration Healthcare\", the \"Company\" or the \"Group\")\n \nTrading update for six months ended 31 July 2025\nNotice of interim results\n \nInspiration Healthcare Group plc (AIM: IHC), the global medical technology company pioneering best-in-class, specialist neonatal intensive care medical devices, provides a trading update for six months ended 31 July 2025.\n \nHighlights\n· Revenue growth of 41% to £24.0 million (H1 FY25: £17.0 million)\n· Improved gross margins due to favourable product mix including strong sales of capital items\n· $6 million humanitarian aid contract fully delivered in the period\n· Strong sales momentum in H1 FY26 expected to continue into H2 FY26\n· Net debt reduced by £1.6 million to £6.7 million (31 January 2025: £8.3 million), strengthening the balance sheet\n \nRevenues for the period were £24.0 million (H1 FY25: £17.0 million) which is a 41% increase on the same period last year, ahead of market expectations, and represents record half year revenues for the Group reflecting the benefits of the back-to-basics approach implemented last year. Gross margins also recovered benefitting from an improved sales mix of higher margin neonatal products, with strong sales of capital items, leading to improved profitability when combined with the impact of cost savings implemented last year.\n \nThe Group's contract with the global humanitarian aid group focusing on child and infant welfare, the largest single contract the Company has won to date, at $6 million for SLE6000 and SLE1500 ventilators plus associated accessories and consumables was fully delivered in the period and a majority of payment received. The remainder of this payment, relating to installation of the equipment, is expected to be received in early H2.\n \nThe Middle Eastern contract is also progressing, with the first shipment of ventilators and accessories delivered in the period and payment received. The remainder of this is contract is expected to be delivered in H2 pending receipt of a letter of credit. \n \nAt 31 July 2025, the Group's net debt (excluding IFRS16 lease liabilities) was £6.7 million, a reduction of £1.6 million from £8.3 million at 31 January 2025 due ...